background logo image

Episode 180

Can You Prevent Dementia? A Neuroscientist Explains

Listen, Watch & Subscribe on:

Watch

Can You Prevent Dementia? A Neuroscientist Explains

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

About the guest

Tommy Wood

Tommy Wood

Neuroscientist, Researcher, and Athletic Performance Consultant

Tommy Wood

Neuroscientist, Researcher, and Athletic Performance Consultant

Dr. Tommy Wood is an Associate Professor of Pediatrics and Neuroscience at the University of Washington, where their lab researches brain injury treatment and long-term cognitive health, and they are a founding trustee of the British Society for Lifestyle Medicine.
Learn more about Tommy

Key Highlights

  • Dr. Tommy Wood argues that believing cognitive decline is inevitable becomes self-fulfilling, since people who expect decline stop engaging in the challenging cognitive and physical activities that actually preserve brain function.
  • Rather than betting on a single “magic drug” to prevent dementia, Dr. Wood believes most cases are preventable through lifestyle, environmental, and societal changes, since brain decline likely isn’t driven by just one mechanism.
  • Dr. Wood presents his 3S framework, stimulus, supply, and support, arguing that challenging the brain, fueling it with proper energy and nutrients, and allowing recovery through sleep and stress management all interact so that improving one area shifts the whole system.
  • Technology and screen time aren’t purely harmful for brain health; complex activities like learning new digital skills or playing certain video games can meaningfully improve cognitive function, especially in older adults, though heavy passive use in younger people tends to be a net negative.
  • The core message is that people have significant agency over their long-term cognitive trajectory regardless of family history or genetics, and building “headroom” through consistent engagement is the primary driver of long-term brain health.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

Does Your Brain Need Carbs? Debunking 4 Myths About a Ketogenic Diet
Perspectives in Metabolic Psychiatry

Does Your Brain Need Carbs? Debunking 4 Myths About a Ketogenic Diet

Ketogenic therapy has emerged as a cutting-edge, effective treatment for various psychiatric conditions, including severe depression, bipolar disorder, and schizophrenia. It also has demonstrated efficacy in treating and…

Read more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
News

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals…

Learn more

Keto For Alzheimer’s: A Treatment Whose Time Has Come
Podcast

Keto For Alzheimer’s: A Treatment Whose Time Has Come

In this Metabolic Mind episode, nutritionist and author Amy Berger (“The Alzheimer’s Antidote”) breaks down why Alzheimer’s is increasingly viewed as “type III diabetes” and a problem of brain energy shortage. She explains how ketogenic diets, MCT oil, and exogenous ketones can help fuel insulin-resistant neurons, support mitochondrial health, and potentially improve cognition in people with mild cognitive impairment or Alzheimer’s disease. Amy also critiques microbiome-focused research, highlights the central role of metabolic health (insulin, triglycerides, weight), and offers practical perspective on using nutritional ketosis as a hopeful, science-based strategy for dementia prevention and treatment.

Learn more

Does Your Brain Need Carbs? Debunking 4 Myths About a Ketogenic Diet
Perspectives in Metabolic Psychiatry

Does Your Brain Need Carbs? Debunking 4 Myths About a Ketogenic Diet

Ketogenic therapy has emerged as a cutting-edge, effective treatment for various psychiatric conditions, including severe depression, bipolar disorder, and schizophrenia. It also has demonstrated efficacy in treating and…

Read more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
News

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals…

Learn more

Keto For Alzheimer’s: A Treatment Whose Time Has Come
Podcast

Keto For Alzheimer’s: A Treatment Whose Time Has Come

In this Metabolic Mind episode, nutritionist and author Amy Berger (“The Alzheimer’s Antidote”) breaks down why Alzheimer’s is increasingly viewed as “type III diabetes” and a problem of brain energy shortage. She explains how ketogenic diets, MCT oil, and exogenous ketones can help fuel insulin-resistant neurons, support mitochondrial health, and potentially improve cognition in people with mild cognitive impairment or Alzheimer’s disease. Amy also critiques microbiome-focused research, highlights the central role of metabolic health (insulin, triglycerides, weight), and offers practical perspective on using nutritional ketosis as a hopeful, science-based strategy for dementia prevention and treatment.

Learn more